Skip Navigation
NIH

Talking Glossary of Genetic Terms

Listen to Definition

Lawrence C. Brody, Ph.D. defines Stop Codon

Stop Codon

A stop codon is a trinucleotide sequence within a messenger RNA (mRNA) molecule that signals a halt to protein synthesis. The genetic code describes the relationship between the sequence of DNA bases (A, C, G, and T) in a gene and the corresponding protein sequence that it encodes. The cell reads the sequence of the gene in groups of three bases. Of the 64 possible combinations of three bases, 61 specify an amino acid, while the remaining three combinations are stop codons.

How to cite this term How to cite this term for research papers


A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Stop Codon

A stop codon is a trinucleotide sequence within a messenger RNA (mRNA) molecule that signals a halt to protein synthesis. The genetic code describes the relationship between the sequence of DNA bases (A, C, G, and T) in a gene and the corresponding protein sequence that it encodes. The cell reads the sequence of the gene in groups of three bases. Of the 64 possible combinations of three bases, 61 specify an amino acid, while the remaining three combinations are stop codons.

Narration Transcription

The genetic code is made up of stretches of three nucleotides in a row, each of which specifies an amino acid to be plugged in to ultimately to make a protein. If we just continually made proteins, we'd have this giant long stretch of nonsense proteins, so we need some punctuation. And there's a special codon called a start codon, which is an ATG, that begins each protein. And then at the end of the proteins we have a special codon called stop codons. There's actually three of those, three different triplets, that tell the translational machinery that's making the protein that here's the place to stop making the protein, and those are called stop codons.


Doctor Profile

Lawrence C. Brody, Ph.D.

Lawrence C. Brody, Ph.D.

Occupation
Chief & Senior Investigator, Genome Technology Branch; Head, Molecular Pathogenesis Section

Biography
Dr. Brody investigates the genetics of breast cancer and neural tube defects. As chief of the NHGRI Genome Technology Branch's Molecular Pathogenesis section, he is interested in studying genetic mutations that lead to perturbations in normal metabolic pathways and cause disorders such as cancer and birth defects. His laboratory investigates mutations in two breast cancer-linked genes, breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2). Dr. Brody's laboratory was among the first to report that women carrying BRCA1 or BRCA2 mutations have a higher risk of developing both breast and ovarian cancer than women without such mutations.

How to cite this termHow to cite this term for research papers

Illustrations

About the Talking Glossary
all Top